Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Apr;20(4):463-464.
doi: 10.1016/S1470-2045(19)30071-3. Epub 2019 Feb 21.

Assessment of breast cancer risk: which tools to use?

Montserrat Garcia-Closas  1 , Nilanjan Chatterjee  2
Affiliations
Comment

Assessment of breast cancer risk: which tools to use?

Montserrat Garcia-Closas et al. Lancet Oncol. 2019 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment on

  • 10-year performance of four models of breast cancer risk: a validation study.
    Terry MB, Liao Y, Whittemore AS, Leoce N, Buchsbaum R, Zeinomar N, Dite GS, Chung WK, Knight JA, Southey MC, Milne RL, Goldgar D, Giles GG, McLachlan SA, Friedlander ML, Weideman PC, Glendon G, Nesci S, Andrulis IL, John EM, Phillips KA, Daly MB, Buys SS, Hopper JL, MacInnis RJ. Terry MB, et al. Lancet Oncol. 2019 Apr;20(4):504-517. doi: 10.1016/S1470-2045(18)30902-1. Epub 2019 Feb 21. Lancet Oncol. 2019. PMID: 30799262

References

    1. Terry MB, Liao Y, Whittemore AS. 10-year performance of four models of breast cancer risk: a validation study. Lancet Oncology 2019; published online Feb 21. 10.1016/S1470-2045(18)30902-1. - DOI - PubMed
    1. Choudhury PP, Wilcox AN, Brook MN, et al. Comparative validation of breast cancer risk prediction models and projections for future risk stratification. bioRxiv 2018; published online Oct 19. DOI:10.1101/440347. - DOI - PMC - PubMed
    1. Brentnall AR, Cuzick J, Buist DSM, Bowles EJA. Long-term accuracy of breast cancer risk assessment combining classic risk factors and breast density. JAMA Oncol 2018; 4: e180174. - PMC - PubMed
    1. Mavaddat N, Michailidou K, Dennis J, et al. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes. Am J Hum Genet 2019; 104: 21–34. - PMC - PubMed
    1. Cuzick J, Brentnall AR, Segal C, et al. Impact of a panel of 88 single nucleotide polymorphisms on the risk of breast cancer in high-risk women: results from two randomized tamoxifen prevention trials. J Clin Oncol 2017; 35: 743–50. - PMC - PubMed